Eli Lilly (LLY) Forms BioCritica for Further Xigris Development
Go back to Eli Lilly (LLY) Forms BioCritica for Further Xigris Development| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1243.61 +17.88 (1.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1225.73 | 52 Week High | $88.16 | |||
| Open | $1245.81 | 52 Week Low | $67.88 | |||
| Day High | $1245.81 | P/E | 287.87 | |||
| Day Low | $1243.61 | EPS | $4.32 | |||
| Volume | 230,022 | |||||

